Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364375534> ?p ?o ?g. }
- W4364375534 endingPage "154819" @default.
- W4364375534 startingPage "154819" @default.
- W4364375534 abstract "Current treatments for lung cancer have their own deficiencies, such as severe adverse effect. Therefore, more safe and effective drugs are needed.Fuzheng Kang-Ai (FZKA for short) has been applied as an adjuvant treatment in advanced Non-Small Cell Lung Cancer (NSCLC) patients for decades in China, showing a definitive effect with minimal toxicities. However, the underlying mechanism is yet to be identified.Both in vitro and in vivo experiments were performed in this study to identify the exact mechanism by which FZKA inhibits NSCLC cell proliferation.MTT and CCK-8 assays were used to detect cell viability. Xenograft model was performed for in vivo experiments. CircRNA and miRNA sequencing were used to find the differentially expressed circRNAs and miRNAs, respectively. qRT-PCR was performed to check the expression levels of circRNA, miRNA and mRNA. BaseScope was carried out to observe the expression of circRNA in situ. Actinomycin D and RNase R experiments were done to show the stability of circRNA. Nuclear-cytoplasmic fractionation and FISH were used to identify the localization of circRNA and miRNA. Pull-down, RIP, and luciferase activity assays were performed to show the biding ability of circRNA, miRNA and target proteins. Flow cytometry was done to observe cell apoptosis. Western blot and IHC were done to detect the protein expression. TCGA database was used to analyze the survival rate.FZKA inhibits NSCLC cell proliferation both in vitro and in vivo. Hsa_circ_0048091 and hsa-miR-378g were the most differentially expressed circRNA and miRNA, respectively, after FZKA treatment. Silencing hsa_circ_0048091 and overexpressing hsa-miR-378g promoted cell proliferation and reversed the inhibition effect of FZKA on NSCLC, respectively. Hsa-miR-378g was sponged by hsa_circ_0048091, and the overexpression of miR-378g reversed the inhibition effect of hsa_ circ_0048091 on NSCLC. ARRDC3, as a target of hsa-miR-378g, was increased by FZKA treatment. Silencing ARRDC3 reversed both the inhibition effect of FZKA and miR-378g inhibitor on NSCLC.This study, for the first time, has established the function of hsa_circ_0048091, hsa- miR-378g, and ARRDC3 in lung cancer. It also shows that FZKA inhibits NSCLC cell proliferation through hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway, uncovering a novel mechanism by which FZKA controls human NSCLC cell growth." @default.
- W4364375534 created "2023-04-12" @default.
- W4364375534 creator A5006632317 @default.
- W4364375534 creator A5021628435 @default.
- W4364375534 creator A5042261970 @default.
- W4364375534 creator A5048419560 @default.
- W4364375534 creator A5057395244 @default.
- W4364375534 creator A5070812231 @default.
- W4364375534 creator A5071868129 @default.
- W4364375534 creator A5076049385 @default.
- W4364375534 creator A5077068949 @default.
- W4364375534 creator A5088937367 @default.
- W4364375534 date "2023-06-01" @default.
- W4364375534 modified "2023-09-26" @default.
- W4364375534 title "Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway" @default.
- W4364375534 cites W1998778049 @default.
- W4364375534 cites W2025422149 @default.
- W4364375534 cites W2031593782 @default.
- W4364375534 cites W2058835062 @default.
- W4364375534 cites W2066993094 @default.
- W4364375534 cites W2147625377 @default.
- W4364375534 cites W2158804744 @default.
- W4364375534 cites W2198093519 @default.
- W4364375534 cites W2228221433 @default.
- W4364375534 cites W2272984102 @default.
- W4364375534 cites W2346875448 @default.
- W4364375534 cites W2531297636 @default.
- W4364375534 cites W2744911560 @default.
- W4364375534 cites W2781525129 @default.
- W4364375534 cites W2784576889 @default.
- W4364375534 cites W2792121315 @default.
- W4364375534 cites W2793167197 @default.
- W4364375534 cites W2795917193 @default.
- W4364375534 cites W2797823977 @default.
- W4364375534 cites W2810477029 @default.
- W4364375534 cites W2883062882 @default.
- W4364375534 cites W2893792076 @default.
- W4364375534 cites W2914398011 @default.
- W4364375534 cites W2970396787 @default.
- W4364375534 cites W3013536544 @default.
- W4364375534 cites W3014207387 @default.
- W4364375534 cites W3031467782 @default.
- W4364375534 cites W3038004940 @default.
- W4364375534 cites W3047618978 @default.
- W4364375534 cites W3104643835 @default.
- W4364375534 cites W3131048422 @default.
- W4364375534 cites W3138471173 @default.
- W4364375534 cites W3142295235 @default.
- W4364375534 cites W3164332865 @default.
- W4364375534 cites W3192493086 @default.
- W4364375534 cites W3196511214 @default.
- W4364375534 cites W4200074879 @default.
- W4364375534 cites W4206841660 @default.
- W4364375534 doi "https://doi.org/10.1016/j.phymed.2023.154819" @default.
- W4364375534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37062135" @default.
- W4364375534 hasPublicationYear "2023" @default.
- W4364375534 type Work @default.
- W4364375534 citedByCount "0" @default.
- W4364375534 crossrefType "journal-article" @default.
- W4364375534 hasAuthorship W4364375534A5006632317 @default.
- W4364375534 hasAuthorship W4364375534A5021628435 @default.
- W4364375534 hasAuthorship W4364375534A5042261970 @default.
- W4364375534 hasAuthorship W4364375534A5048419560 @default.
- W4364375534 hasAuthorship W4364375534A5057395244 @default.
- W4364375534 hasAuthorship W4364375534A5070812231 @default.
- W4364375534 hasAuthorship W4364375534A5071868129 @default.
- W4364375534 hasAuthorship W4364375534A5076049385 @default.
- W4364375534 hasAuthorship W4364375534A5077068949 @default.
- W4364375534 hasAuthorship W4364375534A5088937367 @default.
- W4364375534 hasBestOaLocation W43643755341 @default.
- W4364375534 hasConcept C104317684 @default.
- W4364375534 hasConcept C119056186 @default.
- W4364375534 hasConcept C145059251 @default.
- W4364375534 hasConcept C1491633281 @default.
- W4364375534 hasConcept C150903083 @default.
- W4364375534 hasConcept C153911025 @default.
- W4364375534 hasConcept C185592680 @default.
- W4364375534 hasConcept C190283241 @default.
- W4364375534 hasConcept C207001950 @default.
- W4364375534 hasConcept C502942594 @default.
- W4364375534 hasConcept C53227056 @default.
- W4364375534 hasConcept C553184892 @default.
- W4364375534 hasConcept C55493867 @default.
- W4364375534 hasConcept C62112901 @default.
- W4364375534 hasConcept C86803240 @default.
- W4364375534 hasConceptScore W4364375534C104317684 @default.
- W4364375534 hasConceptScore W4364375534C119056186 @default.
- W4364375534 hasConceptScore W4364375534C145059251 @default.
- W4364375534 hasConceptScore W4364375534C1491633281 @default.
- W4364375534 hasConceptScore W4364375534C150903083 @default.
- W4364375534 hasConceptScore W4364375534C153911025 @default.
- W4364375534 hasConceptScore W4364375534C185592680 @default.
- W4364375534 hasConceptScore W4364375534C190283241 @default.
- W4364375534 hasConceptScore W4364375534C207001950 @default.
- W4364375534 hasConceptScore W4364375534C502942594 @default.
- W4364375534 hasConceptScore W4364375534C53227056 @default.
- W4364375534 hasConceptScore W4364375534C553184892 @default.
- W4364375534 hasConceptScore W4364375534C55493867 @default.